Literature DB >> 20865675

Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease.

Hakan Fotbolcu1, Tolga Yakar, Dursun Duman, Tansu Karaahmet, Kursat Tigen, Cihan Cevik, Unal Kurtoglu, Ismet Dindar.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is considered the liver component of the metabolic syndrome. We investigated the diastolic and systolic functional parameters of patients with NAFLD and the impact of metabolic syndrome on these parameters.
METHODS: Thirty-five non-diabetic, normotensive NAFLD patients, and 30 controls, were included in this study. Each patient underwent transthoracic conventional and tissue Doppler echocardiography (TDI) for the assessment of left ventricular (LV) diastolic and systolic function. Study patients were also evaluated with 24-hour ambulatory blood pressure monitoring.
RESULTS: NAFLD patients had higher blood pressures, increased body mass indices, and more insulin resistance than controls. TDI early diastolic velocity (E' on TDI) values were lower in NAFLD patients than the controls (11.1 ± 2.1 vs 15.3 ± 2.7; p < 0.001). TDI systolic velocity (S' on TDI) values were lower in NAFLD patients than the controls (9.34 ± 1.79 vs 10.6 ± 1.52; p = 0.004). E' on TDI and S' on TDI values were moderately correlated with night-systolic blood pressure, night-diastolic blood pressure, and night-mean blood pressure in NAFLD patients.
CONCLUSIONS: Patients with NAFLD have impaired LV systolic and diastolic function even in the absence of morbid obesity, hypertension, or diabetes.

Entities:  

Mesh:

Year:  2010        PMID: 20865675

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  47 in total

1.  Preclinical cardiac disease in nonalcoholic fatty liver disease with and without metabolic syndrome.

Authors:  Jasbir Makker; Hassan Tariq; Jonathan N Bella; Kishore Kumar; Chukwunonso Chime; Harish Patel; Muhammad Umar Kamal; Danial Shaikh; Vamshidhar Vootla; Bharat Bajantri; Umut Gomceli; Mohammad Alshelleh; Richard Peralta; Aiyi Zhang; Sridhar Chilimuri
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

Review 2.  Non-alcoholic fatty liver disease - the heart of the matter.

Authors:  Haneen Azzam; Stephen Malnick
Journal:  World J Hepatol       Date:  2015-06-08

3.  Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.

Authors:  Lisa B VanWagner; Brittany Lapin; Anton I Skaro; Donald M Lloyd-Jones; Mary E Rinella
Journal:  Liver Int       Date:  2015-06-03       Impact factor: 5.828

Review 4.  Cardiac abnormalities in patients with nonalcoholic fatty liver disease : Insights from auxiliary examinations.

Authors:  Yu Dong; Guangsen Li
Journal:  Herz       Date:  2019-09-19       Impact factor: 1.443

5.  The relationship between coronary artery disease and cardiovascular events early after liver transplantation.

Authors:  Samarth S Patel; Fei-Pi Lin; Viviana A Rodriguez; Chandra Bhati; Binu V John; Taylor Pence; Mohammad B Siddiqui; Adam P Sima; Antonio Abbate; Trevor Reichman; Mohammad S Siddiqui
Journal:  Liver Int       Date:  2019-03-26       Impact factor: 5.828

Review 6.  Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.

Authors:  Stefano Ballestri; Amedeo Lonardo; Stefano Bonapace; Christopher D Byrne; Paola Loria; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 7.  Magnetic Resonance Elastography of Liver: Current Update.

Authors:  Safa Hoodeshenas; Meng Yin; Sudhakar Kundapur Venkatesh
Journal:  Top Magn Reson Imaging       Date:  2018-10

8.  Nonalcoholic fatty liver disease and the heart in children and adolescents.

Authors:  Lucia Pacifico; Claudio Chiesa; Caterina Anania; Antonio De Merulis; John Frederick Osborn; Sara Romaggioli; Eugenio Gaudio
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 9.  Nonalcoholic fatty liver disease as a multi-systemic disease.

Authors:  Hakan Fotbolcu; Elçin Zorlu
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

Review 10.  Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.

Authors:  Alessandro Mantovani; Stefano Ballestri; Amedeo Lonardo; Giovanni Targher
Journal:  Dig Dis Sci       Date:  2016-01-25       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.